Assertion: lopinavir ritonavir | /r/HasAspect | benefit
Facets:
value: for some secondary endpoints
type: PURPOSE
Source sentences:
text: time to clinical improvement beyond the standard of care, although lopinavir–ritonavir was found to have benefit for some secondary endpoints, the safety of the treatment was confirmed, and future trials will verify the results.